Handheld Raman Analyzer from Rigaku Analytical Devices Chosen as Part of U.S. Food and Drug Administration Opioid Inspection Program

Rigaku Analytical Devices, a U.S.-based, leading pioneer of handheld and portable spectroscopic analyzers, is pleased to announce the Rigaku Progeny ResQ 1064 nm handheld Raman analyzer will be used as part of the U.S. FDA inspection pilot program to screen for pharmaceuticals, including narcotics.  The Office of Regulatory Affairs will use this equipment to support increased package inspections for pharmaceutical products including opioids at International Mail Facilities (IMFs).  The Progeny™ ResQ™ analyzer is designed to identify narcotics, including fentanyl, fentanyl analogs, and other narcotics in powder, liquid, and tablet forms.

Rigaku Progeny ResQ 1064nm handheld Raman analyzer

The expansive library, rapid response time, easy operation and ability to scan through glass, plastic and other container material demonstrate why the Progeny ResQ is a highly effective tool for the FDA’s application.  The U.S. Scientific Working Group for the Analysis of Seized Drugs (SWGDRUG) recognizes Raman spectroscopy as a Class A analytical technique for presumptive field testing.

“Because the U.S. FDA and other federal border agencies face exposure to potentially dangerous narcotics and chemicals without warning, these programs have proven how critical it is for our advanced identification tools to be readily available,” said Bree Allen, President of Rigaku Analytical Devices.  “We are extremely pleased to provide a solution for keeping border officials and our communities safer.”        

More information about handheld and portable spectroscopic analyzers from Rigaku is available at www.rigaku.com/handhelds.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Rigaku Analytical Devices. (2019, April 30). Handheld Raman Analyzer from Rigaku Analytical Devices Chosen as Part of U.S. Food and Drug Administration Opioid Inspection Program . AZoM. Retrieved on January 22, 2020 from https://www.azom.com/news.aspx?newsID=51109.

  • MLA

    Rigaku Analytical Devices. "Handheld Raman Analyzer from Rigaku Analytical Devices Chosen as Part of U.S. Food and Drug Administration Opioid Inspection Program ". AZoM. 22 January 2020. <https://www.azom.com/news.aspx?newsID=51109>.

  • Chicago

    Rigaku Analytical Devices. "Handheld Raman Analyzer from Rigaku Analytical Devices Chosen as Part of U.S. Food and Drug Administration Opioid Inspection Program ". AZoM. https://www.azom.com/news.aspx?newsID=51109. (accessed January 22, 2020).

  • Harvard

    Rigaku Analytical Devices. 2019. Handheld Raman Analyzer from Rigaku Analytical Devices Chosen as Part of U.S. Food and Drug Administration Opioid Inspection Program . AZoM, viewed 22 January 2020, https://www.azom.com/news.aspx?newsID=51109.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Submit